Komal Kamra

Publication Details

  • A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.

    Williams GD, Ramamoorthy C, Pentcheva K, Boltz MG, Kamra K, Reddy VM. Paediatr Anaesth. 2008; 18 (9): 812-9

    Neonates undergoing open-heart surgery are especially at risk for massive bleeding and pronounced inflammation. The efficacy of aprotinin, a serine protease inhibitor, at ameliorating these adverse effects of cardiopulmonary bypass has not been clearly demonstrated in neonates.

    PubMedID: 18768040

Stanford Medicine Resources:

Footer Links: